AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY

EIN: 521850793 501(c)(3) Medical Research

CHICAGO, IL

Total Revenue
$8,107,793
Total Expenses
$8,319,833
Total Assets
$11,968,853
Net Assets
$8,806,343
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1993
Legal Domicile
IL
Principal Officer
COREY CUTLER
Phone
3123216820
Tax Period
2023-01-01 to 2023-12-31

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY, founded in 1993, is a community nonprofit in the Medical Research sector that reported $8.1M in total revenue in fiscal year 2023. Revenue grew 11% year-over-year, indicating healthy expansion.

Mission

ASTCT IS AN INTERNATIONAL PROFESSIONAL MEMBERSHIP ASSOCIATION OF MORE THAN 3000 PHYSICIANS, INVESTIGATORS AND OTHER HEALTH CARE PROFESSIONALS FROM MORE THAN 45 COUNTRIES, WHO ARE DEDICATED TO IMPROVING THE APPLICATION AND SUCCESS OF BLOOD AND MARROW TRANSPLANTATION AND RELATED CELLULAR THERAPIES. ASTCT STRIVES TO BE THE LEADING ORGANIZATION PROMOTING RESEARCH, EDUCATION AND CLINICAL PRACTICE IN THE FIELD THROUGH PROMOTING: COMPREHENSIVE DEVELOPMENT AND ADVANCEMENT OF THE FIELD OF BLOOD AND MARROW TRANSPLANTATION; EXCELLENCE IN CLINICAL CARE AND TREATMENT OUTCOMES THROUGH STANDARDS FOR BLOOD AND MARROW TRANSPLANTATION; INNOVATIVE RESEARCH TO ADVANCE THE SCIENCE AND CLINICAL APPLICATIONS OF OTHER CELLULAR THERAPIES; AND, RAPID DISSEMINATION OF BASIC AND CLINICAL BMT RESEARCH FINDINGS WITHIN THE MEDICAL FIELD AND TO THE GENERAL PUBLIC.

Program Service Accomplishments

Program 1
Expenses: $2,529,946 Revenue: $1,932,433

ANNUAL MEETING - ASTCT TYPICALLY HOLDS A GENERAL MEETING WITH THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH ("CIBMTR"), WHERE ADMINISTRATORS, CLINICIANS, DATA MANAGER/CLINICAL...

Read more

ANNUAL MEETING - ASTCT TYPICALLY HOLDS A GENERAL MEETING WITH THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH ("CIBMTR"), WHERE ADMINISTRATORS, CLINICIANS, DATA MANAGER/CLINICAL RESEARCH PROFESSIONALS, FELLOWS IN TRAINING, INVESTIGATORS, LABORATORY TECHNICIANS, MEDICAL DOCTORS, NURSES, NURSE PRACTITIONERS, PHARMACISTS, PHYSICIAN ASSISTANTS, AND OTHER ALLIED HEALTH PROFESSIONALS BENEFIT FROM A FULL SCIENTIFIC PROGRAM; ADDRESSING THE MOST TIMELY ISSUES IN HEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY.

Program 2
Expenses: $1,646,966 Revenue: $259,751

EDUCATION AND CONFERENCES - ASTCT PROVIDES FOCUSED EDUCATION TO IMPROVE RESEARCH, PATIENT OUTCOMES, AND FOSTER PROFESSIONAL DEVELOPMENT THROUGH DIVERSE OUTLETS AND OPPORTUNITIES.

Program 3
Expenses: $1,170,764 Revenue: $816,064

OTHER PROGRAMS - THROUGHOUT THE YEAR, ASTCT OFFERS SPONSORSHIPS IN SUPPORT OF VARIOUS FUNCTIONS, INCLUDING ITS CONTENT HUB. SPONSORSHIP ARE RECOGNIZED RATABLY OVER THE APPLIABLE PERIOD. ASTCT ALSO...

Read more

OTHER PROGRAMS - THROUGHOUT THE YEAR, ASTCT OFFERS SPONSORSHIPS IN SUPPORT OF VARIOUS FUNCTIONS, INCLUDING ITS CONTENT HUB. SPONSORSHIP ARE RECOGNIZED RATABLY OVER THE APPLIABLE PERIOD. ASTCT ALSO RECEIVES A LIMITED AMOUNT OF REVENUES FROM ACTIVITIES, WHICH ARE RECOGNIZED AT A POINT IN TIME IN WHICH THE RELATED PERFORMANCE OBLIGATIONS ARE FULFILLED.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,157,455
Program Service Revenue $5,268,135
Investment Income $233,568
Other Revenue $448,635
TOTAL REVENUE $8,107,793

Expense Breakdown

Grants Paid $930,935
Salaries & Benefits $31,750
Fundraising Expenses $0
Program Expenses $7,445,968
Other Expenses $7,357,148
TOTAL EXPENSES $8,319,833

Year-over-Year Comparison

2023 2022 Change
Revenue $8,107,793 $7,320,416 +0.1%
Expenses $8,319,833 $6,803,644 +0.2%
Net Income $-212,040 $516,772 -1.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
15
Independent Members
14
Employees
N/A
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
9
$30,000
Total Directors
20
$31,750
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
BRENDA SANDMAIER MD PRES UNTIL 2/2023, THEN PAST PRESIDENT 3.00
Officer Director
$0 $0 $0
MIGUEL-ANGEL PERALES MD VP UNTIL 2/2023, THEN PRESIDENT 3.00
Officer Director
$0 $0 $0
STELLA DAVIES PAST PRESIDENT UNTIL 2/2023 3.00
Officer Director
$0 $0 $0
CORY CUTLER MD VP UNTIL 2/2023, THEN PRESIDENT ELECT 3.00
Officer Director
$0 $0 $0
DAVID PORTER MD VICE PRESIDENT AS OF 2/2023 3.00
Officer Director
$30,000 $0 $30,000
AMRIAT KRISHNAN SECRETARY UNTIL 2/2023 3.00
Officer Director
$0 $0 $0
MEHDI HAMADANI MD SECRETARY AS OF 2/2023 3.00
Officer Director
$0 $0 $0
UDAY POPAT MD TREASURER 3.00
Officer Director
$0 $0 $0
BETTY HAMILTON MD DIRECTOR 3.00
Director
$750 $0 $750
NANDITA KHERA MD DIRECTOR 3.00
Director
$0 $0 $0
DIANNA HOWARD MD DIRECTOR 3.00
Director
$0 $0 $0
BRIAN BETTS MD DIRECTOR 3.00
Director
$0 $0 $0
ALAN HANASH MD PHD DIRECTOR 3.00
Director
$0 $0 $0
SUNG-YUN PAI MD DIRECTOR 3.00
Director
$0 $0 $0
KIRSTEN WILLIAMS DIRECTOR 3.00
Director
$0 $0 $0
LORI MUFFLY MD DIRECTOR 3.00
Director
$0 $0 $0
NIRALI SHAH MD DIRECTOR 3.00
Director
$0 $0 $0
LESLIE KEAN DIRECTOR UNTIL 2/2023 3.00
Director
$1,000 $0 $1,000
SHALINI SHENOY DIRECTOR UNTIL 2/2023 3.00
Director
$0 $0 $0
ENEIDA NEMECEK DIRECTOR UNTIL 2/2023 3.00
Director
$0 $0 $0
ANDRE WILLIAMS EXECUTIVE DIRECTOR 40.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $8,107,793 $8,319,833 $11,968,853 $-212,040
2022 $7,565,810 $6,879,329 $11,031,172 $686,481
2021 $5,528,435 $4,797,386 $11,425,659 $731,049
2020 $5,769,745 $4,637,330 $9,607,006 $1,132,415
2020 $5,776,958 $4,406,527 $9,647,006 $1,370,431
2019 $5,433,015 $4,370,323 $8,263,852 $1,062,692
Explore More Nonprofits
Top 100 Nonprofits in Illinois Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY with other nonprofits in Illinois and across the country.